COTA Participates in Reagan-Udall Foundation + Friends of Cancer Research COVID-19 Evidence Accelerator
COTA is actively participating in this collaboration, presenting key findings from ongoing research with Hackensack-Meridian Health involving observational, real-world studies of more than 3,000 hospitalized COVID-19 patients.
Celebrating the Nurses at COTA During National Nurses Week
In recognition of National Nurses Week, we’ve asked COTA’s nurses a few questions about their motivation for becoming a nurse, how their current roles in healthcare technology differs from their experience working in the hospital, and their message to nurses currently on the frontlines of the pandemic.
COTA Collaborates to Understand COVID-19 Using Real-World Evidence – New Findings Published
COTA has partnered with Hackensack Meridian Health (HMH), New Jersey’s largest and most comprehensive health network, and Berry Consultants to conduct an observational real world study of more than 3,000 hospitalized COVID-19 patients.
Dr. Ming He Joins COTA as Senior Medical Director
Today, we are excited to announce the newest addition to our team: Dr. Ming He, COTA’s Senior Medical Director. At COTA, Dr. He will work across the organization, applying her clinical oncology expertise to support various teams including abstraction operations, engineering, product, and analytics.
COTA Team Member Spotlight: Chew Lee
For our April Team Member Spotlight, we are excited to recognize Chew Lee, a Software Engineer on COTA’s engineering team. In addition to his official role as a Software Engineer, Chew also holds the position of being COTA’s Chief Celebration Officer, a role that has become increasingly important as the company adjusts to a completely remote work environment.
COTA, Inc. named a 2020 Fast 50 company by Boston Business Journal
The Boston Business Journal has named COTA, Inc. to its exclusive 2020 Fast 50 list, which represents the 50 fastest-growing private companies in Massachusetts.
Historical Regulatory Use of RWE
Historical uses of RWE in regulatory decision-making are at best sparse, but they provide the precedent on which we are building the foundation of real-world impact. This blog reviews use cases of RWE in regulatory actions.
Managing COVID-19 Among Cancer Patients: Risk & Response
New research shows that cancer patients may be more susceptible to COVID-19 than individuals without cancer, and have poorer outcomes.
COVID-19 & COTA: Perspectives from Mike Doyle, CEO
Reflecting on the weeks ahead as we try to prevent the spread of COVID-19, COTA’s CEO Mike Doyle shares some of the things we’re doing to support our team members at COTA, and highlights promising industry developments.
COTA Team Member Spotlight: The Women of COTA
In honor of International Women’s Day this month, we want to recognize the female colleagues who inspire us to work harder, collaborate more, and fiercely support each other.